MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • 2025 International Congress

    Hemimasticatory Spasm Secondary to an Anterior Inferior Cerebellar Artery Loop Treated with Botulinum Toxin Injection

    K. Kaneko, D. Gonzalez (Phoenix, USA)

    Objective: To present a case of hemimasticatory spasm (HMS) secondary to an anterior inferior cerebellar artery (AICA) loop treated with botulinum injection. Background: HMS is…
  • 2025 International Congress

    Successful Treatment of Hemifacial Spasm with Daxibotulinum Toxin A

    HS. Lee (Sacramento, USA)

    Objective: Botulinum toxin has been an effective and safe treatment option for hemifacial spasm. This is a report of 5 patients with successful treatment of…
  • 2025 International Congress

    Personalised Success: Evaluating Hemifacial Spasm Treatment with Goal Attainment Scale

    S. Maytharakcheep, O. Phokaewvarangkul, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To assess the effectiveness of botulinum toxin A (BoNTA) therapy in treating  hemifacial spasm (HFS) patients using Goal Attainment Scale (GAS). Background: HFS is…
  • 2025 International Congress

    Role of the other babinski sign in hemifacial spasm

    YC. Chen, SL. Chen (Taichung, Taiwan)

    Objective: To investigate the role of the “Other Babinski Sign” in differentiating HFS from blepharospasm and to determine its prevalence in HFS patients. Background: The…
  • 2025 International Congress

    Botulinum toxin therapy in patients with Hemifacial spasm: beyond the treatment of motor symptoms.

    MB. Charra Castellani, MV. Kurtz, E. Knorre, D. Ballesteros (Buenos Aires, Argentina)

    Objective: Evaluate the quality of life and the presence of anxiety and depression in HFS patients and their behavior after botulinum toxin administration. Background: Hemifacial…
  • 2025 International Congress

    Hypersensitivity Reaction to Abobotulinumtoxin: A Case Report

    T. Le, M. Christie (Houston, USA)

    Objective: To report a case of hypersensitivity reaction to abobotulinumtoxinA injections for spasticity in a patient who did not have hypersensitivity to onabotulinumtoxinA and raise…
  • 2025 International Congress

    Simple and Effective OnabotulinumtoxinA Injection Technique for Hemifacial Spasm

    K. Fungpunyaroj, P. Chairangsaris (Bangkok, Thailand)

    Objective: In order to determine fixed-site and fixed-dose BoNT injections for HFS were easy to administer, safe, efficacious, well-tolerated, and practical this study aims to…
  • 2025 International Congress

    Physician Assessment of Non-Medical Toxin Switching on Patient Care

    P. Charles, L. Venditti, M. Nelson, R. Singh, K. Pazira, H. Kling, L. Kopaeva, S. Sharp, K. Harper (Nashville, USA)

    Objective: To gain an understanding from physicians on the impact of non-medical toxin switching (NMTS) in the treatment of movement disorders and other chronic conditions…
  • 2025 International Congress

    IncobotulinumtoxinA to Treat Sialorrhea in Parkinson’s Disease: a Real-life Study: 6-year Interim Results

    B. Bergmans, N. Winter, V. Schotte, N. Sys, E. van Massenhove, G. Pollet, H. Couckuyt, L. Delameilleure, M. van Zandijcke (Bruges, Belgium)

    Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in advanced Parkinson’s disease (PD) patients suffering from sialorrhea. Background: Sialorrhea is frequently a…
  • 2025 International Congress

    Botulinium toxin in treatment of Parkinsonism

    A. Wankar (Nagpur, India)

    Objective: This review discusses the use of BT in various motor and non-motor symptoms of Parkinsonism. This review discusses the use of BT in various…
  • 1
  • 2
  • 3
  • …
  • 13
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley